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Abstract
Several evidences suggest that the pro-inflammatory cytokines IL-1b and the radical NO are implicated as effectors molecules
in the pancreatic b-cells dysfunction; an event preceding the pathogenesis of diabetes. IL-1b induces the expression of the inducible
isoform of NO synthase (iNOS), which use L-arginine as substrate to overproduce NO. However, it is not known whether these
events may participate in the development of diabetic retinopathy, which is the main cause of blindness. In this work, we found
an increased level of IL-1b in retinas from streptozotocin-induced (STZ) diabetic rats. We also observed that the activity of the
NO synthase (NOS) and the L-arginine uptake are enhanced in retinas from STZ-induced diabetic rats as compared to retinas
from control rats. We found that the uptake of L-arginine in retinas from control and diabetic rats occurs through a transporter
resembling the Y system, i.e. it is saturable, not affected over the pH range 6.5 to 7.4, and is independent of the extracellular
Na. Nevertheless, the L-arginine transport in retinas from diabetic rats occurs through a carrier with lower affinity (Km25
mM) and higher capacity (Vmax295922.4 pmol L-arginine:mg protein) than in retinas from control rats (Km5 mM and
Vmax158912.8 pmol L-arginine:mg protein) which is correlated with the increased NOS activity and consequent depletion of
the intracellular pool of L-arginine. © 1999 Elsevier Science Ltd. All rights reserved.
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1. Introduction
L-Arginine is an essential amino acid, predominantly
cationic at the physiological pH range. In most mam-
malian cells, the uptake of extracellular L-arginine oc-
curs via a plasma membrane cationic amino acid (CAT)
transporter system termed Y system. The transport
activity of this Y system is sodium independent,
saturable and pH insensitive (White, 1985; Simmons,
Closs, Cunningham & Smith, 1996). Once inside the
cells, L-arginine may be converted into L-citrulline and
nitric oxide (NO) by two distinct isoforms of the en-
zyme NOS, the constitutive and the inducible isoforms.
NO produced by the constitutive isoform acts as a
signaling molecule whereas the excessive amount of NO
produced through the inducible isoform functions as a
cytotoxic molecule (Bogle, Baydoun, Pearson, Mon-
cada & Mann, 1992; Schmidlin & Wiesinger, 1994;
Aldridge & Collard, 1996). The overproduction of NO
may cause nitrosylation of the Fe–S groups in
mithocondrial enzyme aconitase there by inhibiting glu-
cose oxidation and ATP production which leads to cell
death and tissue damage, as seen in inflammatory disor-
ders and in diabetes (Bogle et al., 1992, Sharma,
Danoff, DePiero & Ziyadeh, 1995; Sobrevia, Nadal,
Yudilevich & Mann, 1996).
In diabetes mellitus there is an increase in plasma
concentration of both, glucose and pro-inflammatory
cytokines, namely IL-1b and TNF-a (El Asrar, Mai-
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mone, Morse, Gregory & Reder, 1992; Welsh, Welsh,
Bendtzen, Mares, Strandell, O8 berg & Sandler, 1995).
These cytokines induce the iNOS expression and conse-
quent NO overproduction in different cell types (Welsh
et al., 1995; Kuemmerle, 1998). Furthermore, high con-
centration of glucose, induces the iNOS expression, and
increases the L-arginine uptake in murine mesanglial
cells (Sharma et al., 1995), in murine macrophages
(Sharma et al., 1995) and in endothelial cells (Sobrevia
et al., 1996).
Although, the causes of diabetic retinopathy still
remain incompletely understood changes in blood reti-
nal barrier (BRB) permeability have been reported in
experimental diabetes mellitus (Vinores, Niel, Swerdloff
& Campochiaro, 1993). Additionally our recent find-
ings have revealed that BRB permeability and retina
glucose concentration are increased in eight days STZ-
induced diabetic rats (Carmo, Ramos, Reis, Proenc¸a &
Cunha-Vaz, 1998a; Carmo, Lopes, Santos, Proenc¸a,
Cunha-Vaz & Carvalho, 1998b). Because both, glucose
and cytokines, namely IL-1, have been implicated in the
pathogenesis of diabetes mellitus (El Asrar et al., 1992;
Rabinovitch & Suarez-Pinzon, 1998; Sjo¨holm, 1998),
the aim of this study was to assess the levels of IL-1
and L-arginine concentration in retinas from STZ-in-
duced diabetic rats, and to evaluate whether L-arginine
uptake and the NOS activity are altered in comparison
with control rats.
Taken together, our results suggest that the increased
level of IL-1b in retinas from STZ-induced diabetic rats
may contribute to the development of inflammatory
conditions, namely the increased production of NO
which may lead to retinal cell death observed in dia-
betic retinopathy.
2. Material and methods
2.1. Chemicals
Streptozotocin (STZ) (60 mg:ml per kg), veratridine
(50 mM), N-methyl-L-arginine (1 mM) monensin (50
mM) and the kit for protein quantification were pur-
chased from Sigma, St Louis, MO. L-[3H]arginine was
purchased from Amersham, Bucks, UK. Dowex AG
50W-X8 was obtained from BioRad, Hertfordshire,
UK. The kit for IL-1b quantification was purchased
from R&D systems, Oxon, UK. The kit for glucose
quantification was purchased from Boheringer, East
Sussex, UK. All other chemicals used in this study were
of analytical grade.
2.2. Animal model
Male Wistar rats (250–300 g body weight) were
anesthetized with ether and injected peritoneally with a
freshly prepared solution of streptozotocin (STZ) (60
mg:ml per kg in 0.1 M citrate buffer, pH 4.5). Control
rats were injected with an equal volume of 0.1 M citrate
buffer. All animals were assessed regularly for weight,
blood glucose and glycosuria. Blood for these analyses
was collected via tail clipping under ether anesthesia.
The blood glucose levels were checked with a colorimet-
ric method based on a standard method, and glycosuria
was assessed with glucose oxidase reagent strips. The
criteria for diabetes was persistent hyperglycemia (\
350 mg:100 ml), glycosuria, polyuria and impaired
growth according to the results obtained in Carmo et
al. (1998a).
2.3. Quantification of IL-1b le6els
To quantify the levels of IL-1b in retinas from con-
trol and STZ-induced diabetic rats, five animals from
each group were killed, the eyes were removed and
retinas without the pigment epithelium were gently
peeled away, washed and sonicated in diluent calibrator
of the kit. The level of IL-1b was then determined by
ELISA according to the kit instructions.
2.4. Nitric oxide synthase acti6ity and L-arginine
concentration in retinas from control and diabetic rats
To determine the NOS activity in control and 8 days
streptozotocin-induced diabetic rats, five animals from
each group were killed, the eyes were removed and
retinas without the pigment epithelium were gently
peeled away, washed and sonicated in HEPES buffer
(20 mM, pH 7.4). The NOS activity was determined in
the retinal lysates by measuring the formation of L-
[3H]citrulline from L-[3H]arginine. Retinal lysates (0.5
mg protein:ml) were incubated for 30 min, at 37°C, in
a total volume of 200 ml of a incubation medium
containing 0.5 mM NADPH, 2 mM Ca2, 1 mM
EGTA, and 10 nM L-[3H]arginine (60 Ci:mmol). The
enzymatic reactions were initiated by addition of retinal
lysates to the incubation medium, and the assays were
terminated using 1.8 ml of STOP solution (50 mM
HEPES, pH 5.5, 5 mM EDTA, at 4°C). The L-
[3H]citrulline was separated from L-[3H]arginine on
Dowex AG 50W-X8 (Na form) columns previously
equilibrated with STOP solution. The L-[3H]citrulline
was eluted with 2 ml of distilled water, and the radioac-
tivity was quantified by liquid-scintillation counter
(Bredt & Snyder, 1989).
To determine the L-arginine concentration the iso-
lated retinas from control and diabetic rats were soni-
cated in 500 ml of HEPES buffer (20 mM, pH 7.4) and
were centrifuged at 20 000 rpm, for 20 min. The super-
natant was collected and stored at 80°C until use.
Amino acid concentrations were measured by high-per-
formance liquid chromatography (HPLC) after deriva-
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tization with o-phthalaldehyde:2-mercaptoethanol, as
previously described (Santos, Moreno & Carvalho,
1996).
2.5. Uptake of L-arginine assays
Eight days after streptozotocin or citrate injection,
five rats from each group were killed, and the eyes were
removed. Retinas were gently peeled away from pig-
ment epithelium, resuspended and washed in Krebs
modified solution (1 mM CaCl2, 132 mM Na, 1.2
mM H3PO4, 4.7 mM KCl, 1.5 mM Hepes–Tris, 5.6
mM glucose and 1.177 mM MgSO4) according to the
experiments. Each retina was divided in four portions
and each portion was weighted to ensure an equaliza-
tion of the samples.
The retinas isolated from control and diabetic ani-
mals were incubated in 200 ml of Krebs modified solu-
tion containing also 10 ml of L-[3H]arginine (63
Ci:mmol) for 30 min, at 37°. After incubation, each
retina portion was washed three times with cold Krebs
modified solution, resuspended in 200 ml of cold
medium and sonicated. The accumulated radioactivity
was estimated by liquid scintillation counting, and the
concentration of the accumulated L-arginine was calcu-
lated from its specific activity. In some experiments
N-metil-arginine (NMA) (1 mM) which inhibits the
L-[3H]arginine uptake by a competitive mechanism
(Lopes, Cardoso, Schousboe & Carvalho, 1994) was
added simultaneously with the L-[3H]arginine to the
incubation medium.
The effect of extracellular pH on the L-[3H]arginine
uptake was studied by incubating retinas from control
and diabetic rats for 30 min, at 37°, on Krebs modified
solution at different pH values (4, 6.5, 7.4 and 8.5). The
extracellular pH was changed by addition of NaOH 1
M or HCl 1 M to the Krebs modified solution.
To study the effect of intracellular pH on the L-
[3H]arginine uptake, retinas from control and diabetic
rats were pre-incubated for 30 min, at 37°, in N-metil-
glucamine (NMG), which is impermeable to the cellular
membrane, in Krebs modified sodium free solution with
monensin (5 mM) an ionophore that transports Na
into the cell in exchange for H, at different pH (4, 6.5,
7.4 and 8.5) without L-[3H]arginine. Retinas were then
incubated for 30 min, at 37°C, in a medium with the
same composition in the presence of 10 ml of L-
[3H]arginine.
To study the effect of extracellular sodium on the
L-[3H]arginine uptake into retina from control and dia-
betic rats two sets of experiments were performed. In
one the extracellular sodium of the Krebs modified
solution was replaced by NMG (132 mM) and in the
other veratridine (50 mM) which in low concentration
induce Na influx, was added to the Krebs modified
solution.
2.6. Statistics
All data are presented as mean9S.E.M. of at least
five separate experiments. Statistical analysis was per-
formed using Stastistica W:5.0 from Statsoft. Student’s
t-test for independent samples was used to compare
differences between the control and the diabetic groups
and Student’s t-test for dependent samples was used to
compare differences between the same group (control
or diabetic).
3. Results
We measured the levels of IL-1b in retinal lysates
from control and STZ-induced diabetic rats and we
correlated them with both the NOS activity and the
L-arginine uptake. We found a significant increase (PB
0.05) in the levels of IL-1b in retina lysates from
diabetic rats (0.3190.08 pg:mg protein) as compared
to that in control rats (0.09390.013 pg:mg protein)
(Fig. 1).
In parallel experiments, as depicted in Fig. 2, we
observed that the NOS activity in retinal lysates from
diabetic rats was significantly increased, PB0.05
(270921 pmol L-[3H]citrulline:mg protein:30 min) as
compared to the NOS activity in retinal lysates from
control rats (125919 pmol L-[3H]citrulline:mg protein:
30 min). The L-arginine concentration in retinal lysates
from diabetic rats was significantly lower, PB0.05
(560930 pmol:mg protein) than that in retinal lysates
from control rats (30109340 pmol:mg protein) (Fig.
2), which is in agreement with an increased activity of
NOS.
Fig. 1. Levels of the cytokine IL-1b in retinal lysates from control and
STZ-induced diabetic rats. The level of IL-1b was determined by
ELISA according to standard method. Data are mean9S.E.M. from
five separate experiments each made in triplicate with retinas from
five control and five STZ-induced diabetic rats. * Significant differ-
ences from control rats (PB0.05).
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Fig. 2. NOS activity and intracellular L-arginine concentration in
retinas from control and STZ-induced diabetic rats. NOS activity was
assayed in an incubation medium containing 0.5 mg protein:ml, 2
mM Ca2, 1 mM EGTA, 0.5 mM NADPH and 10 nM L-
[3H]arginine in a total volume of 200 ml in the absence and in the
presence of the NOS inhibitors, as indicated in Table 1. The intracel-
lular concentration of L-arginine was determined by HPLC as de-
scribed in materials and methods. Data are mean9S.E.M. values of
five separate experiments in triplicate. * Significant differences from
control rats (PB0.05).In the figure [L-arginine]i means intracellular
concentration of L-arginine.
Fig. 4. Effect of methyl-L-arginine (1 mM) on L-[3H]arginine uptake
into the rat retinas isolated from control rats and STZ-induced
diabetic rats. Intact retinas were incubated at 37° for 30 min in Krebs
modified medium, containing L-[3H]arginine (10 nM), cold L-arginine
(10 mM) and NMA (1 mM). The retina was washed, sonicated and
the radioactivity measured as described in material and methods.
Data are mean9S.E.M. of five separate experiments in duplicate.
* Significant differences from the results obtained without NMA
(PB0.05).
Since the production of NO is mainly dependent on
the availability of L-arginine, we studied the character-
istics of the L-arginine uptake in retinas isolated from
control and diabetic rats. In Fig. 3 is indicated the
effect of the temperature on L-arginine uptake, we
observed that at 4°C, there was no difference between
the uptake of L-[3H]arginine into retinas from control
(38.594.2 pmol:mg protein:30 min) and diabetic rats
(39.795.3 pmol:mg protein:30 min). However, at
37°C, the uptake of L-[3H]arginine was significantly
increased in any groups of the retinas, and it was
significantly higher in retinas from diabetic rats (2399
27.6 pmol:mg protein:30 min) than in retinas from
control rats (186914.3 pmol:mg protein:30 min) (Fig.
2), PB0.05. Further, the addition of the L-arginine
analog, N-methyl-L-arginine (NMA), to the incubation
medium inhibited the uptake L-[3H]arginine by 75.8%
(from 186914.3 to 45.0914.8 pmol:mg protein:30
min) in retinas from control rats and by 71.2% (from
239927.6 to 68.8915 pmol:mg protein:30 min) in
retinas from diabetic rats (Fig. 4).
In order to evaluate the time course of the L-
[3H]arginine uptake, the freshly isolated retinas were
continuously incubated for as long as 60 min (from 1 to
60 min), in the presence of L-[3H]arginine (10 nM) and
unlabeled L-arginine (10 mM). The uptake of L-arginine
into retinas from control and diabetic rats followed a
linear time course over 5 min (Fig. 5). The steady state
was reached at 30 min in retinas from control rats
(186914.3 pmol L-arginine:mg protein) and at 45 min
in retinas from diabetic rats (251930.4 pmol L-
arginine:mg protein). The initial rate of the L-arginine
transport was higher in retinas from diabetic rats
(70.7910 pmol L-arginine:mg protein 1 min of incuba-
tion) than in retinas from control rats (58.695.71 pmol
L-arginine:mg protein 1 min of incubation) (Fig. 5).
The maximal transport rate (Vmax) and half satura-
tion constant (Km) of L-[3H]arginine transport were
determined by the Lineweaver–Burk plot over the con-
centration range of 0.5–600 mM of L-arginine (Table 1).
The transport of L-[3H]arginine by retinas from both
control and diabetic rats was saturable (data not
shown). The Vmax value for L-arginine transport is
higher in retinas from diabetic rats (295922.4 pmol:
mg protein) than in retinas from control rats (1589
12.8 pmol:mg protein). The Km value is five times
higher in retinas from diabetic rats (25 mM) than in
retinas from control rats (5 mM) (Table 1). These
findings indicate that the L-arginine transport in retinas
Fig. 3. Effect of the temperature on L-[3H]arginine uptake into the rat
retinas isolated from control and STZ-induced diabetic rats. Intact
retinas were incubated for 30 min in Krebs modified medium, con-
taining L-[3H]arginine (10 nM) and cold L-arginine (10 mM). The
retinas were washed, sonicated and the radioactivity measured as
described in material and methods. Data are mean9S.E.M. of five
separate experiments in duplicate. * Significant differences from the
control rats (PB0.05).
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Fig. 5. Effect of incubation time on L-[3H]arginine uptake into the rat
retinas isolated from control rats and STZ-induced diabetic rats.
Intact retinas were incubated at 37° for different times in Krebs
modified medium, containing L-[3H]arginine (10 nM) and cold L-
arginine (10 mM). The retinas were washed, sonicated and the ra-
dioactivity measured as described in material and methods. Each
value is the mean9S.E.M. of five separate experiments in duplicate.
Fig. 6. Effect of extracellular pH on L-[3H]arginine uptake into the
rat retinas isolated from control rats and STZ-induced diabetic rats.
Intact retinas were incubated at 37° for 30 min in Krebs modified
medium, containing L-[3H]arginine (10 nM) and cold L-arginine (10
mM) at different pH values (4, 6.5, 7.4 and 8.5). The retinas were
washed, sonicated and the radioactivity measured as described in
material and methods. Each value is the mean9S.E.M. of five
separate experiments in duplicate. * Significant differences from the
results obtained at pH 7.4 (PB0.05).
We also examined the effect of intracellular pH on
the L-[3H]arginine uptake in a Krebs modified sodium
free medium at pH ranging from 4.0 to 9.0 (data not
shown). For this, we used the ionophore monensin, that
transports Na into the cell in exchange for H. The
results indicate that no change in the L-[3H]arginine
uptake occur when retinas were exposed to extracellular
or intracellular pH ranging within the pH range 6–8.
The effect of extracellular Na on the uptake of
L-[3H]arginine was studied by replacing the Na by
NMG (132 mM), or by the addition of veratridine (50
mM) to the Krebs modified solution. When sodium was
replaced by NMG or when veratridine was added to
the standard Krebs modified solution the uptake of
L-[3H]arginine into retinas of control and diabetic rats
did not change (Fig. 7).
4. Conclusions
We found that the level of IL-1b in retinal lysates
from diabetic rats was significantly increased as com-
pared to that in retinal lysates from control rats (Fig.
1). Additionally we also observed that in retinas iso-
lated from STZ-induced diabetic rats, there was an
increased activity of the enzyme NOS and a decrease in
the intracellular concentration of L-arginine in compari-
son to the values in control animals (Fig. 2). These
results are consistent with our previous results showing
that iNOS is expressed in retinal cells from STZ-in-
duced diabetic rats (Carmo et al., 1998b). Recent data
also revealed that IL-1 induced overproduction of NO
is dependent on the transport of the extracellular L-
arginine into the cells (Gill, Low & Grigor, 1996;
from diabetic rats occurs through a transporter with
lower affinity and higher capacity than that in retinas
from control rats.
In additional studies, we examined the effect of the
extracellular and the intracellular pH, as well as the
participation of Na ion, on the L-[3H]arginine uptake
into the retinas. At extracelular pH values between 6.5
and 7.4 the uptake of L-[3H]arginine was higher in
retinas from diabetic rats than in retinas from control
rats (Fig. 6). However, in that pH range, the L-
[3H]arginine uptake did not change significantly either
in retinas from control rats or in retinas from diabetic
rats (Fig. 6). At extracelular pH values 4.0 and 8.5, the
uptake of L-[3H]arginine was significant reduced as
compared to the uptake at pH 7.4 either in retinas from
control rats or in retinas from diabetic rats. Neverthe-
less, in both groups of retinas (control and diabetic) the
decrease rate of L-[3H]arginine uptake at pH 4 was
more significant than that at pH 8.5 (Fig. 6).
Table 1
Km and Vmax values for the uptake of L-[
3H]arginine into rat retina
isolated from control rats and eight days STZ-induced diabetic ratsa
Vmax (pmol:mg protein) Km (mM)
5Control rats 158912.8
Diabetic rats 25295922.4
a Intact retinas were incubated for 5 min, at 37° in Krebs modified
medium, containing L-[3H]arginine (10 nM) and different concentra-
tions of cold L-arginine (0.5–600 mM). The retina was washed,
sonicated and the radioactivity measured as described in material and
methods. Each value is the mean9S.E.M. of five separate experi-
ments in duplicate.
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Fig. 7. Effect of sodium, N-metil-glucamine and veratridine on
L-[3H]-arginine uptake into the rat retinas isolated from control rats
and STZ-induced diabetic rats. Intact retinas were incubated at 37°
for 30 min in Krebs modified medium, in the presence or absence of
Na (132 mM), NMG (132 mM), and veratridine (50 mM). In all the
experiments the incubation medium contained also L-[3H]arginine (10
nM), and cold L-arginine (10 mM). The retinas were washed, soni-
cated and the radioactivity measured as described in material and
methods. Each value is the mean9S.E.M. of five separate experi-
ments in duplicate.
arginine has a lower affinity, and a higher capacity than
that of retinas from control rats (Table 1).
It was recently reported that in cytokine-pretreated
myocytes the expression of iNOS is correlated with the
induction of the CAT family of transporters, CAT1,
CAT-2B and CAT-2A (Simmons et al., 1996).
Experiments reported in our work show an increased
production of NO by the retinas from STZ-induced
diabetic rats (Fig. 2). This NO overproduction may be
due to the IL-1b (Fig. 1) and glucose-induced iNOS
expression (Carmo et al., 1998b). These results together
with the comparative kinetic studies of L-arginine trans-
port in retinas from STZ-induced diabetic and control
rats (Table 1; Fig. 5) appear to indicate that the
changes in L-arginine uptake in STZ-induced diabetic
rats are correlated with the expression of the CAT
family transporters different from those expressed in
the retinas from control rats.
Since previous studies report an increased BRB per-
meability after a post intravitreal injection of IL-1b
(Claudio, Martiney & Brosnan, 1994) it seems possible
that in retinas from STZ-induced diabetic rats, the
increased level of IL-1b together with the increased
glucose concentration may contribute to the increased
BRB permeability and consequently to the development
of diabetic retinopathy.
Further studies will be necessary in order to study the
inhibition of IL-1b, NO production and L-arginine
uptake and its implications in blood-retinal barrier
permeability.
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